tailieunhanh - Clinical implications in the shift of syndecan-1 expression from the cell membrane to the cytoplasm in bladder cancer

To determine the diagnostic and prognostic capability of urinary and tumoral syndecan-1 (SDC-1) levels in patients with cancer of the urinary bladder. Methods: SDC-1 levels were quantitated by enzyme-linked immunosorbent assay (ELISA) in 308 subjects (102 cancer subjects and 206 non-cancer subjects) to assess its diagnostic capabilities in voided urine. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN